New inhaler aims to boost oxygen in COPD patients
NCT ID NCT07037836
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 22 times
Summary
This study tests whether an inhaled medication called Treprostinil (Tyvaso) can help people with COPD who have low blood oxygen levels. Ten adults aged 40 and older will use the Tyvaso nebulizer four times daily for four weeks. Researchers will use special MRI scans and breathing tests to see if the drug improves oxygen delivery in the lungs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Asthma Allergy and Airway Center
RECRUITINGDurham, North Carolina, 27705, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.